This commissioned PMI Impact Study covers comprehensive research on pharmaceutical IPR legal framework and enforcement, impact of corruption on enforcement, modus operandi of pharmaceutical counterfeit trade, associated stakeholder impact and best practices to overcome such illicit trade.